ArticleNPJ digital medicine2025

Deep learning model for assessing survival benefits in hepatocellular carcinoma patients undergoing intra-arterial therapies based on proliferative subtype.

Fei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.